Investment of $10 Million in Everlab: Artificial Intelligence Focused on Proactive Healthcare Solutions
Everlab, an innovative AI health platform, has announced the successful completion of a $10 million seed round, led by Left Lane Capital. This investment will propel Everlab's mission to deliver smarter, earlier care through AI combined with clinical expertise, providing lifelong proactive healthcare rather than reactive treatment after illness appearance.
Laura Sillman, Principal at Left Lane Capital, expressed her excitement in supporting Everlab as they build a category-defining platform. She believes that Everlab has built a product and model that makes preventive care scalable, combining clinical depth with software leverage and operational precision.
The funding will primarily be used to accelerate Everlab's international expansion, grow its workforce and clinic network, and significantly enhance the development of its proprietary AI healthtech platform. This platform is designed to deliver personalized, preventive healthcare through advanced diagnostics, AI-driven analysis, and a tiered membership model that integrates comprehensive health screening, digital-first doctor consultations, and intelligent health insights.
Everlab's AI platform integrates with healthcare networks for real-time, longitudinal records. Members have access to services such as blood tests, MRIs, scans, and continuous monitoring. The funding will also support the rollout of a deeply integrated product ecosystem aimed at providing lifelong, proactive care focused on early detection and personalized intervention to reduce chronic disease risks globally.
Ms. Sillman's faith in Everlab's potential is backed by the platform's impressive track record. Everlab has processed over 1 million biomarkers, with 25% yielding abnormal results and 2.5% resulting in life-changing findings. The platform's proprietary AI analyzes health data, automates summaries, detects risks, and recommends actions.
Marc Hermann, Founder and CEO of Everlab, states that the platform aims to provide accessible world-class preventive care. Everlab's strategy involves leveraging AI, clinical expertise, and operational precision to deliver preventive care. The company's goal is to build a new kind of health platform that delivers preventive care designed to make a significant impact.
Everlab's approach to healthcare is centered around delivering smarter, earlier care to millions. With the new funding, Everlab aims to expand internationally, develop its AI healthtech, and build a product ecosystem for lifelong proactive care. This strategic use of funds directly contributes to Everlab’s mission of delivering smarter, earlier care through AI combined with clinical expertise, providing lifelong proactive healthcare rather than reactive treatment after illness appearance.
In a world where most healthcare remains reactive, with chronic disease causing over 70% of deaths, Everlab offers a beacon of hope. By focusing on personalized prevention, Everlab aims to combat this trend and make preventive care a commercial reality. Left Lane Capital, the lead investor in Everlab's $10 million seed round, believes in Everlab's potential to create a category-defining platform.
[1] Everlab Press Release, "Everlab Secures $10 Million Seed Funding to Revolutionize Preventive Healthcare," [date], [URL] [2] Left Lane Capital Press Release, "Left Lane Capital Leads $10 Million Seed Round in Everlab," [date], [URL] [3] Everlab Website, "About Everlab," [date], [URL] [4] Everlab Website, "Our Mission," [date], [URL] [5] Everlab Website, "Our Approach," [date], [URL]
- Everlab's AI health platform, designed to deliver personalized and proactive healthcare, aims to integrate with various sectors such as science, health-and-wellness, fitness-and-exercise, and finance through investing in its development.
- In the realm of technology and artificial intelligence, Everlab's proprietary AI analyzes vast amounts of health data, automates summaries, detects risks, and recommends actions, potentially revolutionizing the industry.
- With the successful completion of a $10 million seed round, led by Left Lane Capital, Everlab plans to leverage this investment to expand into international markets, fostering growth in the health-and-wellness sector while also building a product ecosystem around artificial intelligence, thereby positioning itself as a category-defining platform.
